Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

被引：53
作者：
Krug, LM
Miller, VA
Kalemkerian, GP
Kraut, MJ
Ng, KK
Heelan, RT
Pizzo, BA
Perez, W
McClean, N
Kris, MG
机构：
[1] Cornell Univ, Weill Med Coll, Mem Sloan Kettering Canc Ctr, Dept Med,Div Solid Tumor Oncol,Thorac Oncol Serv, New York, NY 10021 USA
[2] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷 / 02期
关键词：
dolastatin-10; non-small-cell lung cancer;
D O I：
10.1023/A:1008349209956
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：227 / 228
页数：2
相关论文
共 9 条
  • [1] DOLASTATIN-10, A POWERFUL CYTOSTATIC PEPTIDE DERIVED FROM A MARINE ANIMAL - INHIBITION OF TUBULIN POLYMERIZATION MEDIATED THROUGH THE VINCA ALKALOID BINDING DOMAIN
    BAI, R
    PETTIT, GR
    HAMEL, E
    [J]. BIOCHEMICAL PHARMACOLOGY, 1990, 39 (12) : 1941 - 1949
  • [2] Haldar S, 1997, CANCER RES, V57, P229
  • [3] HOLLEN PJ, 1994, CANCER-AM CANCER SOC, V73, P2087, DOI 10.1002/1097-0142(19940415)73:8<2087::AID-CNCR2820730813>3.0.CO
  • [4] 2-X
  • [5] Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification
    Kalemkerian, GP
    Ou, XL
    Adil, MR
    Rosati, R
    Khoulani, MM
    Madan, SK
    Pettit, GR
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (06) : 507 - 515
  • [6] ANTINEOPLASTIC AGENTS .136. THE ISOLATION AND STRUCTURE OF A REMARKABLE MARINE ANIMAL ANTINEOPLASTIC CONSTITUENT - DOLASTATIN 10
    PETTIT, GR
    KAMANO, Y
    HERALD, CL
    TUINMAN, AA
    BOETTNER, FE
    KIZU, H
    SCHMIDT, JM
    BACZYNSKYJ, L
    TOMER, KB
    BONTEMS, RJ
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1987, 109 (22) : 6883 - 6885
  • [7] Pitot HC, 1999, CLIN CANCER RES, V5, P525
  • [8] Tran H. T., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P306
  • [9] Waud W. R., 1993, Proceedings of the American Association for Cancer Research Annual Meeting, V34, P383
1